Spencer Cox @SpencerJCox
There’s more good news on that front too. The U.S. has selected three vaccines to fund for phase 3 trials, and several vaccine candidates worldwide are either in phase 2 or 3 trials. 7/ https://t.co/Ev5SCsxTvJ — PolitiTweet.org